Filing Flows › Comparisons › OSPN vs TLS
OneSpan vs Telos: OSPN and TLS compared
OneSpan is the larger company: $63.9M of revenue in its latest quarter (Q3 2026) against $47.7M for Telos (Q2 2026). Telos is growing faster (+33% against +12% a year earlier). OneSpan is more profitable, with an operating margin of 14.5% against 0.6%.
Where the money goes: OSPN and TLS
OneSpan (OSPN) · Q3 2026
OneSpan, Q3 2026: revenue $63.9M (+12% year over year), operating margin 14.5%, net earnings $7.8M, operating cash flow $16.5M. The chart follows the revenue to costs, profit and cash.
Telos (TLS) · Q2 2026
Telos, Q2 2026: revenue $47.7M (+33% year over year), operating margin 0.6%, net earnings $660K, operating cash flow $8.8M. The chart follows the revenue to costs, profit and cash.
| OneSpan (OSPN) | Telos (TLS) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $63.9M | $47.7M |
| Revenue growth, Y/Y | +12% | +33% |
| Gross margin | 76.3% | 35.0% |
| Operating margin | 14.5% | 0.6% |
| Net earnings | $7.8M | $660K |
| Net margin | 12.2% | 1.4% |
| Operating cash flow | $16.5M | $8.8M |
| Free cash flow | $13.3M | $8.6M |
| Market value | $711M | — |
| P/E | 10.1× | — |
| Analysts’ mean target | $23.50 | — |
Where the revenue comes from
OneSpan
- Subscription: $51.5M (81%)
- Hardware products: $10.5M (16%)
- Perpetual maintenance and services: $1.9M (3%)
Telos
- Service: $40.6M (85%)
- Product: $7.2M (15%)
Questions
Which is bigger, OneSpan or Telos?
OneSpan is the larger company: $63.9M of revenue in its latest quarter (Q3 2026) against $47.7M for Telos (Q2 2026).
Is OneSpan or Telos growing faster?
Telos is growing faster (+33% against +12% a year earlier).
Which is more profitable, OneSpan or Telos?
OneSpan is more profitable, with an operating margin of 14.5% against 0.6%.
More: OneSpan earnings · how OneSpan makes money · Telos earnings · how Telos makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 29, 2026; 10-Q filed Aug 10, 2026). Fiscal quarters can end on different dates. Not investment advice.